N. Samanci Et Al. , "Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience," Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO) , vol.30, Geneva, Switzerland, 2019
Samanci, N. Et Al. 2019. Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience. Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO) , (Geneva, Switzerland).
Samanci, N., Oruc, K., Bedir, S., Celik, E., Degerli, E., Derin, S., ... Demirelli, F. H.(2019). Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience . Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO), Geneva, Switzerland
Samanci, Nilay Et Al. "Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience," Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO), Geneva, Switzerland, 2019
Samanci, Nilay Ş. Et Al. "Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience." Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO) , Geneva, Switzerland, 2019
Samanci, N. Et Al. (2019) . "Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience." Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO) , Geneva, Switzerland.
@conferencepaper{conferencepaper, author={Nilay ŞENGÜL SAMANCI Et Al. }, title={Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience}, congress name={Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO)}, city={Geneva}, country={Switzerland}, year={2019}}